Abbott Labs and Reckitt Benckiser Shares Fall

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.A jury in October found the companies not liable in a case alleging their infant formula products caused necrotizing enterocolitis,
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt Benckiser shares fell after a U.S. judge ordered a retrial of an infant-formula lawsuit that had found in the consumer-goods company's favor. In afternoon trading Friday, London-listed shares were down 2.
Is Abbott Laboratories (ABT) the Best Healthcare Stock For Long-Term Investment?
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
Medical Design & Outsourcing11h
Abbott’s device leader got a big pay bump as sales surged
Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.
The Citizen18h
Abbott sends film crew to highlight partnership with Auburn Community Hospital
Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...
Abbott Laboratories stock underperforms Friday when compared to competitors
This was the stock's fourth consecutive day of losses.
Pharmaceutical Stocks To Research – March 6th
JD.com, Eli Lilly and Company, Abbott Laboratories, Veeva Systems, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.
Strong Earnings Lift Abbott Laboratories Shares
As for earnings, ABT’s fourth-quarter fiscal 2024 earnings report showed sales growth of 9.5% for the year (excluding COVID ...
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...